Better Allergy Testing for Cephalosporin Antibiotics
Part of Immune system & allergy clinical trials.
This study tests better ways to diagnose allergies to common cephalosporin antibiotics, like Keflex and Rocephin. By participating, you may learn if you are truly allergic to these medicines and if they are safe for you to take in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had a possible immediate allergic reaction (like hives, swelling, trouble breathing) to a cephalosporin antibiotic such as cefazolin, ceftriaxone, or cephalexin.
- You do not have a serious medical condition like unstable heart disease, severe lung disease, or kidney failure.
- You are not currently taking certain medications like beta-blockers or ACE inhibitors for blood pressure, or antihistamines/steroids for allergies (within the last 7 days).
- You have not had a bad reaction to two or more different cephalosporin antibiotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how doctors diagnose beta-lactam allergies (a common type of antibiotic allergy). It will validate a risk assessment tool and investigate the underlying causes. If you have a suspected beta-lactam allergy, this study could help you learn your true allergy status.
This study tests a new way to check if you are allergic to the antibiotic teicoplanin using your own blood serum. It aims to help doctors know for sure if you had a severe allergic reaction during a past surgery.
This trial tests a tool to help doctors safely remove a beta-lactam antibiotic allergy (like penicillin) from your medical record. If you are in the hospital and have such an allergy listed, this tool may help you get the right treatment.
This trial tests a new medication called RPT904 in people with IgE-mediated food allergies to foods like peanut, milk, egg, cashew, or walnut. The goal is to see if it reduces allergic reactions when you eat a small amount of the food.
This trial compares a single dose versus two doses of a penicillin-like drug to see if people who think they are allergic to penicillin can safely be told they are not allergic. It is for people with a low-risk penicillin allergy who want to find out if they can use these antibiotics in the future.
This trial studies a direct oral challenge (giving a small dose of the medicine by mouth) to safely confirm whether children truly have a mild, delayed allergy to certain antibiotics like amoxicillin. It aims to help remove inaccurate allergy labels so kids can use these common antibiotics if needed.
Hear when a new Drug Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.